## **Core Concept**
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. They originate from the interstitial cells of Cajal or their precursors. GISTs are characterized by mutations in specific genes, most commonly the **KIT** gene or **PDGFRA** gene, leading to the constitutive activation of tyrosine kinases.

## **Why the Correct Answer is Right**
The most appropriate marker for GIST is **CD117 (c-KIT)**, as approximately 95% of GISTs express this protein. **CD117** is a transmembrane receptor with tyrosine kinase activity, and its detection by immunohistochemistry is a diagnostic hallmark for GIST. The presence of **CD117** positivity supports the diagnosis of GIST and distinguishes it from other gastrointestinal mesenchymal tumors, such as leiomyomas and leiomyosarcomas.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **S-100** can be positive in some GISTs, it is not specific for GIST and can be found in a variety of other tumors, including schwannomas and melanomas.
- **Option B:** **Desmin** is a muscle-specific marker and can be positive in smooth muscle tumors like leiomyomas and leiomyosarcomas but is not specific for GIST.
- **Option D:** **CD34** can be positive in some GISTs but is less specific than **CD117** and can be found in other tumors, including hematopoietic cells and some sarcomas.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that GISTs are often resistant to traditional chemotherapy and radiotherapy. However, targeted therapy with **tyrosine kinase inhibitors**, such as imatinib, has significantly improved the management and prognosis of patients with GIST, especially those with **KIT** or **PDGFRA** mutations.

## **Correct Answer:** . **CD117 (c-KIT)**